Medrobotics® Corporation Receives CE Mark for the Flex® System

Company Prepares for European Commercialization of the Ground-Breaking Flex® System in Otolaryngology

 

FOR IMMEDIATE RELEASE 
Contact: Diane Wilson +1 (978) 656-1258

RAYNHAM, Mass., Mar. 18, 2014- Medrobotics Corp., a medical robotics company, announced today that the Company received the CE mark for the Flex® System and will initiate a limited commercial launch of the product in select European markets.

"The Flex® System is the first robot-assisted flexible endoscopic platform for use during surgical procedures," said Samuel Straface, Ph.D., president and CEO of Medrobotics. “The system enables surgeons to access and visualize hard-to-reach anatomical locations and deploy specially designed flexible surgical instruments to perform procedures."

The Flex® System enables surgical procedures where conventional line-of-sight technologies are either not feasible or sub-optimal. Surgeons can navigate the Flex® Endoscope around anatomical structures to hard-to-reach locations through a single access site, then use the onboard high-definition vision system to precisely deploy a range of third party flexible surgical instruments. The uniquely “wristed” 3mm Flex® Instruments enable the surgeon to operate in confined spaces, further extending his or her reach to important and often challenging areas of the anatomy.

"The Flex® System provides a unique platform to access and visualize surgical targets in difficult to reach locations such as the oropharynx and endolarynx,” commented Dr. Marshall Strome, Professor and Chairman Emeritus, Cleveland Clinic Head and Neck Institute and Co-Chair of Medrobotics Medical Advisory Board. “With currently available technologies, we are often trading off between access, visualization and two-handed surgery, but the Flex® System gives us all three,” added Strome.

Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex® System was designed to provide a cost-effective, easy-to-use robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex® System, a robotic-assist platform that enables surgeons to gain single-site access and visualization to hard-to-access anatomical locations. The system provides a precise and stable platform for enhanced visualization and enables two-handed dexterity with compatible third-party instruments having tactile feedback. The Company has received the CE Mark for its products and is commercializing in Europe. These products are currently not approved for sale in the U.S.

 

 

Medrobotics Closes $20 Million Financing: Company Extends its Runway for Commercialization of the Ground-Breaking Flex® System in Otolaryngology, Oct. 20, 2014 More

Medrobotics Announces Launch of the Flex® Retractor, Sept. 18, 2014 More

Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg, Sept. 1, 2014 More

Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics' Flex® System, July 20, 2014 More

University Hospital Dinant Godinne-UCL Namur Completes World’s First Robotic-Assisted Surgery with Medrobotics‘ Flex® System, June 18, 2014 More

Medrobotics Closes $26 Million Series E Financing, May 13, 2014 More

Medrobotics Corporation Receives CE Mark for the Flex® System, Mar. 18, 2014 More

Medrobotics Appoints Russell M. Singleton, Ph.D., as Senior Vice-President R&D, Mar. 17, 2014 More

Medrobotics Appoints Thomas F. Patzelt Vice-President Marketing, Jan. 2, 2014 More

Medrobotics Gains ISO 13485: 2003 Certification for the Design, Manufacture, Service and Distribution of the Flex™ System, Nov. 3, 2013 More

Medrobotics Closes On $10 Million Financing From Hercules, March 22, 2013 More

Medrobotics Appoints Richard S. Walsh Vice-President Global Sales, Feb. 4, 2013 More

Medrobotics Completes $33.6 Million Series D Financing: Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology, Dec. 20, 2012
More

Medrobotics Corporation. ©2014. All rights reserved.   Legal Information  •  Privacy Policy